Pinebridge Investments L.P. grew its holdings in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 42.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,825 shares of the business services provider's stock after acquiring an additional 4,437 shares during the quarter. Pinebridge Investments L.P.'s holdings in Exponent were worth $1,321,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently modified their holdings of the business. Westside Investment Management Inc. purchased a new stake in Exponent during the third quarter valued at about $26,000. Private Trust Co. NA increased its position in shares of Exponent by 129.8% during the 4th quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock valued at $25,000 after purchasing an additional 157 shares during the last quarter. Atala Financial Inc purchased a new position in shares of Exponent during the 4th quarter valued at about $25,000. Tortoise Investment Management LLC lifted its position in Exponent by 76.7% in the 4th quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider's stock worth $39,000 after buying an additional 191 shares during the last quarter. Finally, Trust Co. of Vermont bought a new stake in Exponent in the 4th quarter worth approximately $45,000. Hedge funds and other institutional investors own 92.37% of the company's stock.
Insider Buying and Selling
In other news, VP Richard Reiss sold 1,736 shares of the stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total transaction of $149,174.48. Following the completion of the sale, the vice president now owns 1,800 shares of the company's stock, valued at approximately $154,674. This represents a 49.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 2.10% of the stock is owned by corporate insiders.
Exponent Price Performance
NASDAQ EXPO traded down $1.04 on Friday, reaching $76.78. 585,746 shares of the company's stock traded hands, compared to its average volume of 241,659. The stock has a market cap of $3.90 billion, a PE ratio of 36.22 and a beta of 0.84. Exponent, Inc. has a 12 month low of $73.37 and a 12 month high of $115.75. The stock has a 50-day simple moving average of $80.59 and a 200 day simple moving average of $89.67.
Exponent (NASDAQ:EXPO - Get Free Report) last released its earnings results on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, beating the consensus estimate of $0.48 by $0.04. The company had revenue of $137.44 million for the quarter, compared to analyst estimates of $134.63 million. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same quarter last year, the firm earned $0.59 EPS. The firm's quarterly revenue was up .2% compared to the same quarter last year. As a group, analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current year.
Exponent Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.56%. The ex-dividend date of this dividend is Friday, June 6th. Exponent's dividend payout ratio is presently 56.60%.
Exponent Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Recommended Stories

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.